Results 11 to 20 of about 47,873 (195)

Aspirin resistance [PDF]

open access: yesJournal of Thrombosis and Haemostasis, 2005
Treatment failures occur with any drug and aspirin is no exception. Evidence is growing to indicate that there are subpopulations that do not respond to antithrombotic action of aspirin. The term 'aspirin resistance' has been used to describe a number of different phenomena, including inability of aspirin to: (i) protect against cardiovascular events ...
J. Musiał   +3 more
openaire   +3 more sources

Long Non-Coding RNA H19 Positively Associates With Aspirin Resistance in the Patients of Cerebral Ischemic Stroke

open access: yesFrontiers in Pharmacology, 2020
Background and purposeAspirin is a novel anti-platelet drug that is intensively recommended for the prevention and treatment of cerebral ischemic stroke.
Jue Wang   +8 more
doaj   +1 more source

Прогностическое значение аспиринорезистентности при ишемической болезни сердца [PDF]

open access: yes, 2008
Рассмотрены данные литературы о значении аспиринорезистентности при ИБС. Предложен разработанный авторами новый экспресс−метод определения чувствительности к аспирину.
Adolescent development: Characteristics and determinants   +11 more
core   +5 more sources

Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. [PDF]

open access: yes, 2006
BACKGROUND AND PURPOSE: Aspirin resistance may be relatively common and associated with adverse outcome. Meta-analysis has clearly shown that 75 mg plain aspirin is the lowest effective dose; however, it is not known whether the recent increased use of ...
Byrne, Michael F   +5 more
core   +1 more source

Aspirin resistance in patients with acute coronary syndrome. Part 2

open access: yesКардиоваскулярная терапия и профилактика, 2011
Aim. In patients with acute coronary syndrome (ACS), to investigate the prevalence of aspirin resistance, its clinical features, prognostic effects, and potential correction. Material and methods.
N. S. Frolova   +4 more
doaj   +1 more source

TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN

open access: yesРациональная фармакотерапия в кардиологии, 2015
Low dose aspirin reduces the secondary incidence of myocardial infarction and stroke. Drug resistance to aspirin might result in treatment failure.
A. I. Martynov   +3 more
doaj   +3 more sources

Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms

open access: yesPlatelets, 2018
Essential thrombocythemia (ET) and polycythemia vera (PV) are myeloproliferative neoplasms (MPN) with an increased risk of arterial and venous thrombosis.
Andréas Perrier-Cornet   +5 more
doaj   +1 more source

Mechanistic view into the therapeutic effect, anticancer potential and the adverse effect of aspirin [PDF]

open access: yesMATEC Web of Conferences
In this research, the working mechanism behind the therapeutic effect of aspirin will be discussed in detail. Aspirin will also be assessed as a promising drug to treat cancerous cells in the future.
Ouyang Juan
doaj   +1 more source

Platelet Function Assays for the Diagnosis of Aspirin Resistance

open access: yesPlatelets, 2022
Aspirin, an antiplatelet drug, is commonly used at low doses for numerous indications, including prophylaxis of cardiovascular, neurovascular, and venous thromboembolic events.
Nameer Van Oosterom   +3 more
doaj   +1 more source

Decreased sensitivity to aspirin is associated with altered polyamine metabolism in human prostate cancer cells [PDF]

open access: yes, 2015
Acknowledgments We thank NHS Grampian for financial support of this work.Peer reviewedPublisher ...
Cameron, Gary A.   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy